newsfilter
← Latest News
PR Newswire·

GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology

Entered into an acquisition deal of 3 programsYONGIN, South Korea, <